ASTRAZENECA TUNES DRUG PORTFOLIO

被引：0
|
作者：
不详
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2015年 / 93卷 / 31期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] Drug development is at risk from proposed takeover of AstraZeneca, MPs are told
    O'Dowd, Adrian
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [42] Bioanalysis - but not as we knew it: an AstraZeneca perspective of the last 10years evolution to meet a diversifying portfolio
    Hawthorne, Glen
    Henderson, Neil
    Holtta, Mikko
    Stovold, Craig
    Wahlander, Asa
    Wilson, Amanda
    BIOANALYSIS, 2019, 11 (07) : 595 - 599
  • [43] Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca
    Kettle, Jason G.
    Wilson, David M.
    DRUG DISCOVERY TODAY, 2016, 21 (10) : 1596 - 1608
  • [44] DRUG DISCOVERY AstraZeneca to spin off antibiotics after no buyers emerge
    Jarvis, Lisa
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (10) : 9 - 9
  • [45] US drug firm Pfizer seeks to buy UK company AstraZeneca
    Jack, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [46] AstraZeneca
    不详
    JOCCA-SURFACE COATINGS INTERNATIONAL, 1999, 82 (06): : 272 - 272
  • [47] Biogen boosts MS drug portfolio
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2017, 95 (48) : 15 - 15
  • [48] The impact of pharmacovigilance on drug portfolio management
    Bucurescu, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (15) : 2237 - 2239
  • [49] Application of portfolio optimization to drug discovery
    Yevseyeva, Iryna
    Lenselink, Eelke B.
    de Vries, Alice
    IJzerman, Adriaan P.
    Deutz, Andre H.
    Emmerich, Michael T. M.
    INFORMATION SCIENCES, 2019, 475 : 29 - 43
  • [50] A portfolio model of drug development for tuberculosis
    Glickman, SW
    Rasiel, EB
    Hamilton, CD
    Kubataev, A
    Schulman, KA
    SCIENCE, 2006, 311 (5765) : 1246 - 1247
12345